Skip to main content
Completed Clinical Trials

Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment

By April 24, 2017No Comments

Condition

Malignant Pleural Mesothelioma

Estimated Enrollment: 78

Age Group: 18 Years to 85 Years   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: 86/12/02

Study First Received: November 10, 2010

Last Updated: November 17, 2010

Estimated Primary Completion Date: June 2010

 

Primary Outcome Measures:

Response rate|Safety and tolerability

Sponsors and Collaborators:

Institute of Oncology Ljubljana|Ministry of Higher Education, Science and Technology, Solvenia

Website Link: https://ClinicalTrials.gov/show/NCT01243632

Leave a Reply